New Intravenous Calcimimetic Agents: New Options, New Problems. An Example on How Clinical, Economical and Ethical Considerations Affect Choice of Treatment

New Intravenous Calcimimetic Agents: New Options, New Problems. An Example on How Clinical, Economical and Ethical Considerations Affect Choice of Treatment

Background. Dialysis treatment is improving, but several long-term problems remain unsolved, including metabolic bone disease linked to chronic kidney disease (CKD-MBD). The availability of new, efficacious but expensive drugs (intravenous calcimimetic agents) poses ethical problems, especially in t...

Full description

Bibliographic Details
Main Authors: Giorgina Barbara Piccoli, Tiziana Trabace, Antoine Chatrenet, Carlos Alberto Carranza de La Torre, Lurlinys Gendrot, Louise Nielsen, Antioco Fois, Giulia Santagati, Patrick Saulnier, Nicola Panocchia
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:International Journal of Environmental Research and Public Health
Subjects:
principlist ethics
drug choice
hemodialysis
calcimimetic agents
non-compliance
economic aspects of drug choice
Online Access:https://www.mdpi.com/1660-4601/17/4/1238

Internet

https://www.mdpi.com/1660-4601/17/4/1238

Similar Items